Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
daniel.anthony@pharm.ox.ac.uk

Telephone
+44 (0)1865 281135

Research groups

Anthony Group | Experimental Neuropathology

Colleges

Somerville College

Daniel C Anthony

Professor of Experimental Neuropathology

Recent publications

Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness
Journal article

Yates AG. et al, (2021)
Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis.
Journal article

Roodselaar J. et al, (2021), Neurol Neuroimmunol Neuroinflamm, 8
Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers.
Journal article

Vahsen BF. et al, (2021), Nat Rev Neurol
Acute IL-1RA treatment suppresses the peripheral and central inflammatory response to spinal cord injury.
Journal article

Yates AG. et al, (2021), J Neuroinflammation, 18
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis.
Journal article

Probert F. et al, (2021), Brain Commun, 3

More publications